NCT03639155View on ClinicalTrials.gov

A Study in Evaluating Bioequivalence Between Test and Reference Formulations of Vadadustat Tablets in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 12, 2018

Primary Completion Date

May 23, 2018

Study Completion Date

May 23, 2018

Conditions
Healthy
Interventions
DRUG

vadadustat reference tablets

oral tablet

DRUG

vadadustat test tablets

oral tablet

Trial Locations (1)

21225

Research Site, Baltimore

Sponsors
All Listed Sponsors
lead

Akebia Therapeutics

INDUSTRY

NCT03639155 - A Study in Evaluating Bioequivalence Between Test and Reference Formulations of Vadadustat Tablets in Healthy Adults | Biotech Hunter | Biotech Hunter